tiprankstipranks
Trending News
More News >
Immunovant (IMVT)
NASDAQ:IMVT

Compare Immunovant (IMVT) vs. Competitors

Compare
923 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Immunovant
$22.98
$4.68B
-10.43
16.71%
8 Buy
2 Hold
0 Sell
Strong Buy
Protagonist Therapeutics
$98.87
$6.31B
-42.66
86.37%
10 Buy
1 Hold
0 Sell
Strong Buy
Crinetics Pharmaceuticals
$35.57
$3.72B
-8.91
3.61%
12 Buy
0 Hold
0 Sell
Strong Buy
Mirum Pharmaceuticals
$88.51
$5.34B
-169.72
84.90%
8 Buy
0 Hold
0 Sell
Strong Buy
Kymera Therapeutics
$77.91
$6.36B
-21.09
134.60%
17 Buy
1 Hold
0 Sell
Strong Buy
MoonLake Immunotherapeutics
$16.27
$1.17B
-3.74
-60.01%
11 Buy
2 Hold
2 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
IMVT
Immunovant
22.98
3.54
18.21%
PTGX
Protagonist Therapeutics
98.87
46.34
88.22%
CRNX
Crinetics Pharmaceuticals
35.57
-0.37
-1.03%
MIRM
Mirum Pharmaceuticals
88.51
41.49
88.24%
KYMR
Kymera Therapeutics
77.91
44.21
131.19%
MLTX
MoonLake Immunotherapeutics
16.27
-24.31
-59.91%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts